Conclusion Overall, when it comes to prescribing GLP1-RAs for weight loss to patients with a history of cholelithiasis or other gallbladder disorders, providers should use caution
For some people with underlying medical conditions, including diabetes or imbalanced hormones, no matter how much exercise they do or how much junk they cut out of their diet, they cant seem to lose weight
Currently, except for LIR and SMG, the numbers of related clinical studies of other GLP-1R agonists are few, especially in obese or overweight people without diabetes
While these programs may improve access for eligible patients, many consumers still face coverage limits, eligibility requirements, and out-of-pocket costs that influence which options they consider
The precise cause is multifactorial
Akyol, O., Zoroglu, S